The regulation of similar biotherapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.

Biosimilars Forum 2019 is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.

Join us in Mexico and trigger a quantum leap in Latin American Healthcare!

Who will
you meet?

More than:








Managing Directors

Managers and Specialists

From these areas:

  • Biosimilars
  • Biobetters
  • Biotechnology
  • Biotherapeutics
  • Analytical science
  • Regulatory compliance
  • Quality Control
  • Clinical immunology
  • Scientific Affairs
  • Pharmacovigilance


Patricia Aprea

Patricia Aprea

ANMAT, Argentina. Director of Evaluation and Control of Biologicals and Radiopharmaceuticals Read More
Maria Fernanda Thees

Maria Fernanda Thees

ANVISA, Brazil. Health Regulation and Surveillance Specialist Read More

Leah Christl

Leah Christl

Amgen, US. Executive Director, Global Regulatory and R&D Policy, JAPAC Lead and Global Biosimilars Read More
Vivian lee

Vivian lee

Bayer, Colombia. Director of Medical Affairs Read More
Ector Jaime Ramirez

Ector Jaime Ramirez

Partido acción nacional de Guanajuato, Mexico. Diputado Federal LXIV Legislatura y secretario de la comision de salud Read More
  • 1
  • 2
  • 3
  • 4

Programme at a Glance

Regulatory Framework in Argentina, Brazil and Mexico
Maria Fernanda Thees ANVISA, Brazil Health Regulation and Surveillance Specialist

Patricia Aprea ANMAT, Argentina Director of Evaluation and Control of Biologicals and Radiopharmaceuticals

Current Development and Regulatory Challenges in the Region
New Commercial Agreements in the region How to Make a Commercial Decision Based on Competitors and Management Models to Boost Biosimilars
Expectations from the Mexican Academy
Regulatory Harmonisation Activities by Argentina, Brazil and Mexico
Pharmacovigilance. Signal Management. Safety Surveillance. Risk communication
Full programme in the PDF Agenda

2018 Video Recap

Keep me updated

About "JackLeckerman"

JackLeckerman Company has been established as a business intelligence event services and the promotion of global summits, strategic conferences, open forums and professional training.

©2019 JackLeckerman. All Rights Reserved. Designed By